Filing Details

Accession Number:
0001179110-12-005695
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-23 17:09:48
Reporting Period:
2012-03-22
Filing Date:
2012-03-23
Accepted Time:
2012-03-23 17:09:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239128 W Greg Linder 100 Abbott Park Road
Abbott Park IL 60064-6400
Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2012-03-22 12,677 $52.55 169,558 No 4 M Direct
Common Shares Without Par Value Acquisiton 2012-03-22 10,630 $56.30 180,188 No 4 M Direct
Common Shares Without Par Value Acquisiton 2012-03-22 13,548 $58.71 193,736 No 4 M Direct
Common Shares Without Par Value Acquisiton 2012-03-22 1,851 $54.74 195,587 No 4 M Direct
Common Shares Without Par Value Disposition 2012-03-22 600 $60.06 194,987 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 1,000 $60.06 193,987 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 400 $60.07 193,587 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 2,300 $60.07 191,287 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 200 $60.08 191,087 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 1,308 $60.08 189,779 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 300 $60.09 189,479 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 2,000 $60.09 187,479 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 18,942 $60.10 168,537 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 100 $60.11 168,437 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 3,584 $60.11 164,853 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 400 $60.12 164,453 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 2,572 $60.12 161,881 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 300 $60.13 161,581 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 2,000 $60.13 159,581 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 1,000 $60.14 158,581 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 1,100 $60.14 157,481 No 4 S Direct
Common Shares Without Par Value Disposition 2012-03-22 600 $60.14 156,881 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2012-03-22 12,677 $0.00 12,677 $52.55
Common Shares Option (right to buy) Disposition 2012-03-22 10,630 $0.00 10,630 $56.30
Common Shares Option (right to buy) Disposition 2012-03-22 13,548 $0.00 13,548 $58.71
Common Shares Option (right to buy) Disposition 2012-03-22 1,851 $0.00 1,851 $54.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2007-07-30 2013-02-13 No 4 M Direct
0 2008-02-10 2013-02-13 No 4 M Direct
0 2009-02-07 2013-02-13 No 4 M Direct
0 2009-08-26 2013-02-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 4,021 Indirect Profit Sharing Trust
Footnotes
  1. Balance in the Abbott Laboratories Stock Retirement Trust as of March 21, 2012.
  2. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.